Yüklüyor......
Suicidality in a Placebo-Controlled Fluoxetine Study of Body Dysmorphic Disorder
OBJECTIVES: SRIs are considered the first-line medication for body dysmorphic disorder (BDD). The relationship between SRI treatment and suicidality in BDD has been only minimally studied, despite high suicidality rates in BDD. METHODS: Sixty-seven adults with DSM-IV BDD participated in a 12-week ra...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2677723/ https://ncbi.nlm.nih.gov/pubmed/19060721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0b013e32831db2e9 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|